VIYASH SCIENTIFIC Financial Statement Analysis
|
||
|
The Revenues of VIYASH SCIENTIFIC have increased by 13.75% YoY .
The Earnings Per Share (EPS) of VIYASH SCIENTIFIC has increased by 336.56 % YoY. |
||
VIYASH SCIENTIFIC Last 5 Annual Financial Results
[BOM: 512529|NSE : VIYASH]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹3,420 Cr | ₹3,007 Cr | ₹1,370 Cr | ₹1,421 Cr | ₹1,413 Cr |
| Expenses | ₹2,768 Cr | ₹2,623 Cr | ₹1,308 Cr | ₹1,409 Cr | ₹1,303 Cr |
| Operating Profit (Excl OI) | ₹653 Cr | ₹384 Cr | ₹61 Cr | ₹12 Cr | ₹109 Cr |
| Other Income | ₹44 Cr | ₹36 Cr | ₹11 Cr | ₹6.39 Cr | ₹11 Cr |
| Interest | ₹69 Cr | ₹86 Cr | ₹48 Cr | ₹36 Cr | ₹16 Cr |
| Depreciation | ₹234 Cr | ₹239 Cr | ₹62 Cr | ₹56 Cr | ₹52 Cr |
| Profit Before Tax | ₹349 Cr | ₹13 Cr | ₹-55 Cr | ₹-138 Cr | ₹53 Cr |
| Profit After Tax | ₹225 Cr | ₹16 Cr | ₹-30 Cr | ₹-122 Cr | ₹45 Cr |
| Consolidated Net Profit | ₹177 Cr | ₹23 Cr | ₹-36 Cr | ₹-121 Cr | ₹41 Cr |
| Earnings Per Share (Rs) | ₹4.06 | ₹0.93 | ₹-1.44 | ₹-4.86 | ₹1.65 |
| PAT Margin (%) | 6.57 | 0.52 | -2.10 | -8.39 | 3.10 |
| ROE(%) | 9.06 | 1.11 | -4.85 | -18.95 | 6.56 |
| ROCE(%) | 13.10 | 4.80 | -0.60 | -9.71 | 7.01 |
| Total Debt/Equity(x) | 0.16 | 0.27 | 0.78 | 0.62 | 0.49 |
Key Financials |
||
| Market Cap | : | ₹ 11,119.5 Cr |
| Revenue (TTM) | : | ₹ 3,148.7 Cr |
| Net Profit(TTM) | : | ₹ 213.8 Cr |
| EPS (TTM) | : | ₹ 4.8 |
| P/E (TTM) | : | 52.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| VIYASH SCIENTIFIC | 1.9% | -5.3% | 37.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.8% | -1.7% | 14.6% |
| DIVIS LABORATORIES | 2.6% | 9.8% | 54.8% |
| TORRENT PHARMACEUTICALS | 2.4% | -0.5% | 36% |
| CIPLA | 1.8% | -3.7% | -11.4% |
| DR REDDYS LABORATORIES | 4.5% | 1.8% | -10% |
| MANKIND PHARMA | 6.2% | 1.9% | -10.3% |
| LUPIN | 3.2% | -3.8% | 4.8% |
| ZYDUS LIFESCIENCES | 5.7% | 4.8% | 11.2% |
VIYASH SCIENTIFIC Revenues
[BOM: 512529|NSE : VIYASH]
| Y-o-Y | 13.75 % |
| 5 Yr CAGR | 24.74 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,420 Cr | 13.75 | |
| Mar2025 | ₹3,007 Cr | 119.52 | |
| Mar2024 | ₹1,370 Cr | -3.60 | |
| Mar2023 | ₹1,421 Cr | 0.57 | |
| Mar2022 | ₹1,413 Cr | - | |
VIYASH SCIENTIFIC Operating Profit
[BOM: 512529|NSE : VIYASH]
| Y-o-Y | 69.93 % |
| 5 Yr CAGR | 56.28 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹653 Cr | 69.93 | |
| Mar2025 | ₹384 Cr | 525.27 | |
| Mar2024 | ₹61 Cr | 413.71 | |
| Mar2023 | ₹12 Cr | -89.07 | |
| Mar2022 | ₹109 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 49.41 % |
| 5 Yr CAGR | 25.30 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 19.08% | 49.41 | |
| Mar2025 | 12.77% | 185.04 | |
| Mar2024 | 4.48% | 433.33 | |
| Mar2023 | 0.84% | -89.15 | |
| Mar2022 | 7.74% | - | |
VIYASH SCIENTIFIC Profit After Tax
[BOM: 512529|NSE : VIYASH]
| Y-o-Y | 663.53 % |
| 5 Yr CAGR | 44.24 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹177 Cr | 663.53 | |
| Mar2025 | ₹23 Cr | Positive | |
| Mar2024 | ₹-36 Cr | Negative | |
| Mar2023 | ₹-121 Cr | Negative | |
| Mar2022 | ₹41 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 1,163.46 % |
| 5 Yr CAGR | 20.66 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 6.57 % | 1,163.46 | |
| Mar2025 | 0.52 % | Positive | |
| Mar2024 | -2.1 % | Negative | |
| Mar2023 | -8.39 % | Negative | |
| Mar2022 | 3.1 % | - | |
VIYASH SCIENTIFIC Earnings Per Share (EPS)
[BOM: 512529|NSE : VIYASH]
| Y-o-Y | 336.56 % |
| 5 Yr CAGR | 25.25 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.06 | 336.56 | |
| Mar2025 | ₹0.93 | Positive | |
| Mar2024 | ₹-1.44 | Negative | |
| Mar2023 | ₹-4.86 | Negative | |
| Mar2022 | ₹1.65 | - | |
VIYASH SCIENTIFIC Return on Capital Employed (ROCE)
[BOM: 512529|NSE : VIYASH]
| Y-o-Y | 172.92 % |
| 5 Yr CAGR | 16.92 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 13.1% | 172.92 | |
| Mar2025 | 4.8% | Positive | |
| Mar2024 | -0.6% | Negative | |
| Mar2023 | -9.71% | Negative | |
| Mar2022 | 7.01% | - | |
VIYASH SCIENTIFIC Share Price vs Sensex
| Current Share Price | : | ₹251.8 |
| Current MarketCap | : | ₹ 11,119.5 Cr |
| Updated EOD on | : | Sep 21,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIYASH SCIENTIFIC | 1.9% |
-5.3% |
37.8% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
VIYASH SCIENTIFIC related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 1.5% | 2.8% | 15.8% |
| BSE 1000 | -0% | -1.9% | -0.9% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY TOTAL MARKET | -0.1% | -2.1% | -0.9% |
| NIFTY SMALLCAP 500 | -0.6% | 0.4% | NA |
| NIFTY MICROCAP 250 | -1.2% | 0.8% | 10.9% |
You may also like the below Video Courses
FAQ about VIYASH SCIENTIFIC Financials
How the annual revenues of VIYASH SCIENTIFIC have changed ?
The Revenues of VIYASH SCIENTIFIC have increased by 13.75% YoY .
How the Earnings per Share (EPS) of VIYASH SCIENTIFIC have changed?
The Earnings Per Share (EPS) of VIYASH SCIENTIFIC has increased by 336.56 % YoY .
Check out Intrinsic Value of Peers of VIYASH SCIENTIFIC
Compare Stock Analytics of Peers of VIYASH SCIENTIFIC
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
